The DePuy ASR Timeline Leading Up to Recall

DePuy, a division of Johnson & Johnson, developed the ASR hip to compete with a rival company’s artificial hip resurfacing device.  The ASR had unique design features and was made of metal on metal components, which ultimately caused it to fail in numerous patients. 

The ASR has been shown to shed excessive metal debris and ions.  Moreover, the ASR has shown wear, pain, popping, clicking, and grinding in individuals, as the internal components of the device wear against each other. 

DePuy began selling the ASR overseas in 2003 and in the United States in 2005.  DePuy marketed and sold the ASR as a cutting-edge hip implant that would produce less wear and metal ions, and last longer in patients. 

Despite information indicating otherwise, DePuy continued selling and marketing the ASR’s safety.  In September 2009, DePuy took the product off the market in Australia. Numerous DePuy ASR patients have complained about these now- recalled products to the Food and Drug Administration since 2008.  Nonetheless, it was not until March 2010 that DePuy first addressed these complaints.  At that time, DePuy issued a Field Safety Notice to physicians regarding the surgical revision rates of its ASR patients.  DePuy told doctors in that urgent notice that surgical revision rates of its ASR metal-on-metal products were higher than expected.  In April 2010, the UK Medicines and Healthcare products Regulatory Agency (MHRA) issued a Medical Device Alert warning of the dangers of all metal-on-metal hip implants.

DePuy waited until August 2010 before it formally recalled the product in the United States.  Approximately 93,000 devices have been implanted worldwide, according to DePuy.  The company does not keep track of the identities of the patients who receive the implants. 

DePuy Individuals who received the recalled devices may have been asked to establish a claim number with Broadspire, sign authorizations allowing the release of private medical records, and seek reimbursement for medical, mileage or other expenses.  Gomez Iagmin Trial Attorneys encourage individuals with the recalled device to speak with an attorney before taking any of those steps.  The remedies available under the law may be much greater than what is being offered by Broadspire and DePuy.

Contact Gomez Iagmin Trial Attorneys, and we will help you determine what type of hip implant you have and what remedies may be available to you under the law.



I understand and agree that The Gomez Law Firm will have no duty to keep confidential the information I am now transmitting to the law firm.  I understand and agree that The Gomez Law Firm has not expressly or implicitly agreed to establish a client-lawyer relationship with me.  I understand and agree that my transmittal of this information does not establish a client-attorney relationship.

 

 

Video Center
Facebook LinkedIn